ZA200303472B - Process for rapid microorganism typing and associated kit of regents. - Google Patents
Process for rapid microorganism typing and associated kit of regents. Download PDFInfo
- Publication number
- ZA200303472B ZA200303472B ZA200303472A ZA200303472A ZA200303472B ZA 200303472 B ZA200303472 B ZA 200303472B ZA 200303472 A ZA200303472 A ZA 200303472A ZA 200303472 A ZA200303472 A ZA 200303472A ZA 200303472 B ZA200303472 B ZA 200303472B
- Authority
- ZA
- South Africa
- Prior art keywords
- dna
- solution
- electrophoresis
- miniplugs
- reagent kit
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 138
- 230000008569 process Effects 0.000 title claims abstract description 38
- 244000005700 microbiome Species 0.000 title description 64
- 238000001962 electrophoresis Methods 0.000 claims abstract description 95
- 230000005012 migration Effects 0.000 claims abstract description 67
- 238000013508 migration Methods 0.000 claims abstract description 67
- 230000005684 electric field Effects 0.000 claims abstract description 51
- 239000012634 fragment Substances 0.000 claims abstract description 44
- 238000003906 pulsed field gel electrophoresis Methods 0.000 claims abstract description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 35
- 239000002738 chelating agent Substances 0.000 claims abstract description 5
- 229910052751 metal Inorganic materials 0.000 claims abstract description 5
- 239000002184 metal Substances 0.000 claims abstract description 5
- 239000003599 detergent Substances 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 161
- 239000000243 solution Substances 0.000 claims description 69
- 229920000936 Agarose Polymers 0.000 claims description 58
- 230000001580 bacterial effect Effects 0.000 claims description 31
- 238000000926 separation method Methods 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 25
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000000872 buffer Substances 0.000 claims description 22
- 238000004364 calculation method Methods 0.000 claims description 20
- 239000007983 Tris buffer Substances 0.000 claims description 18
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 17
- 230000007023 DNA restriction-modification system Effects 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 239000011543 agarose gel Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 241000894007 species Species 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 8
- 238000002844 melting Methods 0.000 claims description 7
- 230000008018 melting Effects 0.000 claims description 7
- 241000191967 Staphylococcus aureus Species 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 claims description 5
- 239000008051 TBE buffer Substances 0.000 claims description 5
- 238000005452 bending Methods 0.000 claims description 5
- 108020000946 Bacterial DNA Proteins 0.000 claims description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- 238000007711 solidification Methods 0.000 claims 3
- 230000008023 solidification Effects 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 2
- 238000005266 casting Methods 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 13
- 241000894006 Bacteria Species 0.000 abstract description 10
- 244000045947 parasite Species 0.000 abstract description 8
- 239000007853 buffer solution Substances 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000001257 hydrogen Substances 0.000 abstract description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 2
- 235000021251 pulses Nutrition 0.000 description 87
- 210000004027 cell Anatomy 0.000 description 69
- 239000000499 gel Substances 0.000 description 42
- 210000000349 chromosome Anatomy 0.000 description 23
- 238000004458 analytical method Methods 0.000 description 18
- 239000000523 sample Substances 0.000 description 17
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 16
- 229960001484 edetic acid Drugs 0.000 description 16
- 230000002255 enzymatic effect Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 12
- 102000053602 DNA Human genes 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 241000224432 Entamoeba histolytica Species 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 9
- 238000004422 calculation algorithm Methods 0.000 description 8
- 239000006285 cell suspension Substances 0.000 description 8
- 241000320412 Ogataea angusta Species 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 238000001853 pulsed-field electrophoresis Methods 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 6
- 210000003812 trophozoite Anatomy 0.000 description 6
- 108010067770 Endopeptidase K Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 229940007078 entamoeba histolytica Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000002759 chromosomal effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 241000235058 Komagataella pastoris Species 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000006161 blood agar Substances 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000002101 lytic effect Effects 0.000 description 3
- 230000002438 mitochondrial effect Effects 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000012146 running buffer Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 238000009631 Broth culture Methods 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- TXWRERCHRDBNLG-UHFFFAOYSA-N cubane Chemical compound C12C3C4C1C1C4C3C12 TXWRERCHRDBNLG-UHFFFAOYSA-N 0.000 description 2
- 230000003544 deproteinization Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000000819 hypertonic solution Substances 0.000 description 2
- 229940021223 hypertonic solution Drugs 0.000 description 2
- 210000001822 immobilized cell Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108010009719 mutanolysin Proteins 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229940016590 sarkosyl Drugs 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 229940055835 triptone Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 241001293418 Mannheimia haemolytica Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- WTGQALLALWYDJH-AKTDCHNFSA-N scopolamine hydrobromide Chemical compound Br.C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@@H](C2)[C@H]2[C@@H]3O2)C)=CC=CC=C1 WTGQALLALWYDJH-AKTDCHNFSA-N 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007221 ypg medium Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44773—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Electrochemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20000247A CU23095A1 (es) | 2000-11-07 | 2000-11-07 | Proceso para la tipificación rápida de microorganismos y juego de reactivos empleado |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200303472B true ZA200303472B (en) | 2003-11-11 |
Family
ID=40134841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200303472A ZA200303472B (en) | 2000-11-07 | 2003-05-06 | Process for rapid microorganism typing and associated kit of regents. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7731828B2 (de) |
| EP (1) | EP1350852B1 (de) |
| JP (1) | JP3955817B2 (de) |
| CN (1) | CN100532569C (de) |
| AT (1) | ATE350490T1 (de) |
| AU (1) | AU2002214939A1 (de) |
| BR (1) | BR0115172B1 (de) |
| CA (1) | CA2428313C (de) |
| CU (1) | CU23095A1 (de) |
| CY (1) | CY1106369T1 (de) |
| DE (1) | DE60125832T2 (de) |
| DK (1) | DK1350852T3 (de) |
| EC (1) | ECSP034577A (de) |
| ES (1) | ES2276843T3 (de) |
| HK (1) | HK1063822A1 (de) |
| MX (1) | MXPA03004006A (de) |
| PT (1) | PT1350852E (de) |
| WO (1) | WO2002038802A1 (de) |
| ZA (1) | ZA200303472B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
| US20040158447A1 (en) * | 2003-02-07 | 2004-08-12 | Dupont Canada Inc. | Method for simulating and modeling the presence and growth of microbes, including pathogens and spoilage organisms, through a food supply chain |
| US20080079726A1 (en) * | 2006-07-03 | 2008-04-03 | Wolfgang Geiger | Visual display of process sequences |
| US20080044821A1 (en) * | 2006-08-21 | 2008-02-21 | Gafur Zainiev | Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes |
| US20090286694A1 (en) * | 2006-08-21 | 2009-11-19 | Gafur Zainiev | Nucleic acid array with releaseable nucleic acid probes |
| US20080044822A1 (en) * | 2006-08-21 | 2008-02-21 | Gafur Zainiev | Nucleic acid array with releaseable nucleic acid probes |
| US20100056388A1 (en) * | 2006-08-21 | 2010-03-04 | Cnvgenes, Inc. | Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes |
| WO2012170560A2 (en) * | 2011-06-06 | 2012-12-13 | Cornell University | Microfluidic device for extracting, isolating, and analyzing dna from cells |
| EP2721140B1 (de) | 2011-06-19 | 2016-11-23 | Abogen, Inc. | Vorrichtungen, lösungen und verfahren zur probenentnahme |
| CN103196980B (zh) * | 2013-03-27 | 2014-10-08 | 中国水产科学研究院淡水渔业研究中心 | 鱼源链球菌脉冲场凝胶电泳快速分型方法 |
| US9999856B2 (en) | 2013-07-26 | 2018-06-19 | General Electric Company | Methods for electroelution of biomolecules |
| US9333463B2 (en) | 2013-07-26 | 2016-05-10 | General Electric Company | Devices and systems for elution of biomolecules |
| PT3114225T (pt) * | 2014-03-07 | 2021-07-26 | Dna Genotek Inc | Composição e método para estabilização de ácidos nucleicos em amostras biológicas |
| CN105372318B (zh) * | 2014-08-28 | 2018-01-05 | 山东省肿瘤医院 | 将细胞原位电泳与流式分析术结合的细胞固定方法 |
| CN104561326B (zh) * | 2015-01-16 | 2017-02-22 | 天津医科大学 | 一种基于菌毛多样性的尿路感染大肠杆菌的分型方法 |
| US11383240B2 (en) | 2016-05-22 | 2022-07-12 | Cornell University | Single cell whole genome amplification via micropillar arrays under flow conditions |
| WO2018051374A1 (en) | 2016-09-15 | 2018-03-22 | Dianax S.R.L. | Microfluidic device, particularly of the lab-on-chip type, for the concentration, purification, and detection of biological and/or medical targets of interest from a biological sample |
| KR102388753B1 (ko) * | 2020-07-20 | 2022-04-20 | 광주과학기술원 | 유전영동 힘을 이용한 미생물 검출 장치 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4707237A (en) * | 1982-09-09 | 1987-11-17 | Ciba Corning Diagnostics Corp. | System for identification of cells by electrophoresis |
| US4861448A (en) * | 1982-11-18 | 1989-08-29 | The Trustees Of Columbia University In The City Of New York | Electrophoretic methods employing gel inserts |
| US4473452A (en) | 1982-11-18 | 1984-09-25 | The Trustees Of Columbia University In The City Of New York | Electrophoresis using alternating transverse electric fields |
| CA2052037A1 (en) * | 1990-10-02 | 1992-04-03 | Eric Lai | Automatic control system for improved electrophoresis |
| FR2693209B1 (fr) * | 1992-07-03 | 1994-09-30 | Inst Nat Sante Rech Med | Procédé de détermination de la taille en nucléotides de fragments d'ADN. |
| WO1995014768A2 (en) * | 1993-11-29 | 1995-06-01 | Gen-Probe Incorporated | Method for extracting nucleic acids from a wide range of organisms |
| ATE294386T1 (de) * | 1998-02-16 | 2005-05-15 | Mallinckrodt Inc | Behälter für ein elektroforetisches gel und zugehöriges verwendungsverfahren |
-
2000
- 2000-11-07 CU CU20000247A patent/CU23095A1/es unknown
-
2001
- 2001-11-02 AU AU2002214939A patent/AU2002214939A1/en not_active Abandoned
- 2001-11-02 MX MXPA03004006A patent/MXPA03004006A/es active IP Right Grant
- 2001-11-02 WO PCT/CU2001/000008 patent/WO2002038802A1/es active IP Right Grant
- 2001-11-02 DK DK01983428T patent/DK1350852T3/da active
- 2001-11-02 CN CNB018203035A patent/CN100532569C/zh not_active Expired - Fee Related
- 2001-11-02 BR BRPI0115172-0A patent/BR0115172B1/pt not_active IP Right Cessation
- 2001-11-02 JP JP2002542115A patent/JP3955817B2/ja not_active Expired - Fee Related
- 2001-11-02 DE DE60125832T patent/DE60125832T2/de not_active Expired - Lifetime
- 2001-11-02 ES ES01983428T patent/ES2276843T3/es not_active Expired - Lifetime
- 2001-11-02 US US10/415,950 patent/US7731828B2/en not_active Expired - Fee Related
- 2001-11-02 AT AT01983428T patent/ATE350490T1/de active
- 2001-11-02 PT PT01983428T patent/PT1350852E/pt unknown
- 2001-11-02 CA CA2428313A patent/CA2428313C/en not_active Expired - Lifetime
- 2001-11-02 EP EP01983428A patent/EP1350852B1/de not_active Expired - Lifetime
-
2003
- 2003-05-06 ZA ZA200303472A patent/ZA200303472B/en unknown
- 2003-05-07 EC EC2003004577A patent/ECSP034577A/es unknown
-
2004
- 2004-09-01 HK HK04106583.6A patent/HK1063822A1/xx not_active IP Right Cessation
-
2007
- 2007-03-12 CY CY20071100340T patent/CY1106369T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106369T1 (el) | 2011-10-12 |
| ES2276843T3 (es) | 2007-07-01 |
| PT1350852E (pt) | 2007-03-30 |
| CA2428313C (en) | 2010-09-14 |
| DK1350852T3 (da) | 2007-05-07 |
| HK1063822A1 (en) | 2005-01-14 |
| US7731828B2 (en) | 2010-06-08 |
| ATE350490T1 (de) | 2007-01-15 |
| JP3955817B2 (ja) | 2007-08-08 |
| WO2002038802A1 (es) | 2002-05-16 |
| CU23095A1 (es) | 2005-11-18 |
| BR0115172B1 (pt) | 2014-10-21 |
| DE60125832D1 (de) | 2007-02-15 |
| ECSP034577A (es) | 2003-08-29 |
| CN1479790A (zh) | 2004-03-03 |
| EP1350852B1 (de) | 2007-01-03 |
| JP2004513375A (ja) | 2004-04-30 |
| US20040050700A1 (en) | 2004-03-18 |
| CA2428313A1 (en) | 2002-05-16 |
| AU2002214939A1 (en) | 2002-05-21 |
| BR0115172A (pt) | 2004-02-17 |
| EP1350852A1 (de) | 2003-10-08 |
| CN100532569C (zh) | 2009-08-26 |
| MXPA03004006A (es) | 2004-04-02 |
| DE60125832T2 (de) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2428313C (en) | Method for rapid typification of microorganisms by pulse field gel electrophoresis (pfge) whereby the samples are prepared in an autoclave and flexible mould | |
| Kaufmann | Pulsed-field gel electrophoresis | |
| Humphery‐Smith et al. | Proteome research: complementarity and limitations with respect to the RNA and DNA worlds | |
| Cai et al. | Ordered restriction endonuclease maps of yeast artificial chromosomes created by optical mapping on surfaces. | |
| Lopez-Canovas et al. | Pulsed field gel electrophoresis: past, present, and future | |
| Pfaller et al. | Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia | |
| Gerring et al. | [4] Positional mapping of genes by chromosome blotting and chromosome fragmentation | |
| Diggle et al. | Pyrosequencing™: Sequence typing at the speed of light | |
| Boekhout et al. | The use of karyotyping in the systematics of yeasts | |
| Alleman et al. | Analysis of the Anaplasma mavginale genome by pulsed-field electrophoresis | |
| Roberts et al. | High-throughput yeast two-hybrid screening | |
| He et al. | Pulsed-field gel electrophoresis typing of Staphylococcus aureus strains | |
| Schein et al. | High-throughput BAC fingerprinting | |
| Montoya et al. | Electrophoretic Karyotype of Clinical Isolates ofParacoccidioides brasiliensis | |
| Chee | Enzymatic multiplex DNA sequencing | |
| Reed et al. | Pulsed-field gel electrophoresis of MRSA | |
| Jolley | Multi-locus sequence typing | |
| Santos-Sanches et al. | Pulsed-field gel electrophoresis (PFGE): application in population structure studies of bovine mastitis-causing streptococci | |
| Gemmill et al. | Pulsed‐field gel electrophoresis for long‐range restriction mapping | |
| Sayada et al. | Denaturing gradient gel electrophoresis analysis for the detection of point mutations in the Chlamydia trachomatis major outer-membrane protein gene | |
| Michaud et al. | 15 Molecular Methods for Bacterial Strain Typing | |
| Hillier et al. | Pulsed field gel electrophoresis | |
| Giusti et al. | Effect of storage conditions on restriction fragment length polymorphism (RFLP) analysis of Deoxyribonucleic Acid (DNA) bound to positively charged nylon membranes | |
| Duim et al. | Amplified fragment-length polymorphism and protein profiling for identification of Campylobacter lari subgroups | |
| JPH10506281A (ja) | 種間または種内相同遺伝子産物の同定 |